Navigating the market for low-cost research compounds requires balancing budgetary constraints against rigorous analytical standards. When sourcing MOTS-c, evaluating purity verification, synthesis quality, and endotoxin metrics is critical to ensuring baseline experimental reproducibility in preclinical models.
Navigating the market for low-cost research compounds requires balancing budgetary constraints against rigorous analytical standards. When sourcing MOTS-c, evaluating purity verification, synthesis quality, and endotoxin metrics is critical to ensuring baseline experimental reproducibility in preclinical models.
Searching for cheap MOTS-c often exposes research facilities to under-synthesized, low-purity, or contaminated peptides that compromise experimental reproducibility. True cost efficiency in laboratory research relies on procuring lot-verified MOTS-c tested via RP-HPLC and mass spectrometry to ensure sequence fidelity, low endotoxin levels, and high stability without sacrificing analytical rigor.
In academic and private laboratory settings, the financial pressure to optimize reagent procurement can make discounted or unverified suppliers appealing. However, procuring lower-tier peptides frequently leads to batch-to-batch variation, incomplete peptide sequences, residual cleavage solvents, or elevated bacterial endotoxin levels. These compounding variables destabilize in vitro assays and animal models, resulting in false negatives, unrepeatable data, or complete experimental failure.
Evaluating the true cost of MOTS-c for research use extends beyond the initial purchase price. Reputable U.S. domestic suppliers mitigate financial risk by pairing stringent manufacturing protocols with verifiable batch documentation. By analyzing analytical reports prior to acquisition, research teams protect baseline assays from data corruption caused by substandard synthetic peptides.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome rather than the nuclear DNA. Identified as a key signal-transducing molecule, MOTS-c belongs to an emerging class of mitochondrial-derived peptides that act as metabolic regulators across diverse cellular environments.
Unlike nuclear-encoded peptides, mitochondrial-derived peptides are synthesized within the organelle or generated via specific mitochondrial open reading frames (sORFs). MOTS-c translocates to the nucleus under cellular stress conditions, where it interacts with specific response elements to modulate gene expression related to nutrient sensing, metabolic homeostasis, and stress response.
Understanding the molecular structure of MOTS-c is vital when assessing peptide quality. Synthetic MOTS-c requires precise step-wise solid-phase peptide synthesis (SPPS) to construct its specific 16-residue primary sequence (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg). Truncated sequences or deletion peptides—frequent byproducts of cheap, unrefined manufacturing processes—fail to mimic native target binding, altering experimental outcomes.
Preclinical investigations primarily evaluate MOTS-c for its role in mitochondrial function, metabolic regulation, and exercise-capacity research. Animal models demonstrate that MOTS-c signaling acts systemically to influence skeletal muscle responsiveness, lipid clearance, and systemic insulin sensitivity under metabolic stress.
In rodent models evaluating metabolic challenges, administration of MOTS-c has been observed to prevent high-fat-diet-induced insulin resistance and body weight gain. Preclinical data indicate that these effects are largely mediated by enhancing glucose utilization in skeletal muscle tissue and altering intracellular nutrient-sensing cascades.
Additionally, exercise-capacity research highlights MOTS-c as an exercise-induced signaling factor (exercise factor or 'exerkine'). Preclinical studies suggest that physical exertion upregulates endogenous MOTS-c expression in both skeletal muscle and systemic circulation. Researchers investigating physical performance parameters utilize synthetic MOTS-c in controlled animal models to observe changes in oxidative phosphorylation, steady-state ATP output, and treadmill run-time to exhaustion.
The principal molecular mechanism attributed to MOTS-c involves the activation of 5'-AMP-activated protein kinase (AMPK), a central regulator of cellular energy balance. In vitro assays demonstrate that MOTS-c increases intracellular levels of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase inhibitors, leading to downstream activation of the AMPK cascade.
Once AMPK is phosphorylated, downstream metabolic pathways are engaged. In cell culture models, MOTS-c exposure leads to increased GLUT4 transporter translocation to the plasma membrane, facilitating glucose uptake independent of classical insulin pathways. Concurrently, MOTS-c suppresses fatty acid synthesis genes while upregulating pathways governing mitochondrial biogenesis.
Under metabolic or oxidative stress, MOTS-c undergoes nuclear translocation. In vitro data indicate that inside the nucleus, MOTS-c binds to specific transcription factors, such as Nrf2 (nuclear factor erythroid 2-related factor 2), to regulate antioxidant response elements (ARE). This dual role—acting both as a cytoplasmic metabolic regulator and a nuclear transcriptional cofactor—makes MOTS-c a critical target in systemic energy research.
When suppliers offer cheap MOTS-c, cost savings are typically achieved by skipping critical purification steps or using low-grade synthesis reagents. Solid-Phase Peptide Synthesis (SPPS) generates target peptides along with truncated peptides, racemized side products, and residual organic solvents such as trifluoroacetic acid (TFA), piperidine, and dimethylformamide (DMF).
Without rigorous high-performance liquid chromatography (HPLC) purification, these synthesis byproducts remain in the final lyophilized powder. When introduced into delicate cell lines or animal models, residual solvents induce cytotoxicity, while truncated sequence variants compete with full-length MOTS-c for receptor targets or nuclear binding sites, generating skewed empirical data.
Furthermore, unverified synthesis batches often contain variable water content or salt forms, resulting in inaccurate molar calculations during laboratory reconstitution. Researchers sourcing low-cost compounds without verifiable analytical data risk spending far more in lost lab hours, compromised tissue cultures, and non-reproducible trial runs than the initial reagent discount provided.
Ensuring research validity requires strict verification of compound purity through transparent analytical testing. Reputable suppliers validate every lot of MOTS-c using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). For detailed standards, explore our guide on analytical HPLC testing criteria.
RP-HPLC determines the chemical purity of the sample by separating the target sequence from residual isomers, deletions, and chemical reagents. PX1 Research mandates that every batch of MOTS-c achieves ≥98% purity as measured by peak area integration. ESI-MS confirms the exact molecular mass (1220.5 Da), verifying that the primary amino acid sequence is fully intact without missing residues or modifications.
Endotoxin testing via Limulus Amebocyte Lysate (LAL) assays is an equally vital metric. Bacterial endotoxins (lipopolysaccharides) provoke immune and inflammatory responses in cell cultures and live animal models, confounding biological measurements. Providing lot-specific, third-party Certificates of Analysis (COAs) ensures that researchers receive compounds free from critical biological and chemical impurities.
Proper handling and storage are necessary to maintain the integrity of synthetic MOTS-c post-delivery. Lyophilized MOTS-c should be stored at -20°C or -80°C in a desiccated environment away from light to prevent premature hydrolysis or oxidation of sensitive residues like methionine and tryptophan.
When preparing MOTS-c for in vitro or animal models, reconstitution should be performed using sterile, bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS), depending on experimental design. Reconstitution protocols must avoid aggressive mechanical agitation; gentle vortexing or passive dissolution protects the secondary structure of the peptide chain.
Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles, which degrade peptide bonds over time. Reconstituted MOTS-c aliquots should be maintained at -80°C for long-term storage or kept short-term at 4°C for immediate assay administration. Review our complete catalog of research peptides for laboratory use for complementary reagents.
In mitochondrial and metabolic research, MOTS-c is frequently evaluated alongside other targeted peptide compounds to isolate specific pathways. For instance, SS-31 research peptide (Elamipretide) is a synthetic tetrapeptide that targets the inner mitochondrial membrane, specifically binding to cardiolipin to reduce reactive oxygen species (ROS) and optimize ATP synthesis without directly translocating to the nucleus.
Similarly, research exploring Humanin research literature focuses on another mitochondrial-derived peptide encoded by the 16S rRNA gene. While Humanin exerts broad cytoprotective, anti-apoptotic, and neuroprotective signaling across cellular models, MOTS-c exhibits a more specialized regulatory role over systemic glucose metabolism, GLUT4 translocation, and metabolic stress responses.
Choosing between these compounds depends on the targeted pathway: MOTS-c serves as the primary tool for research into AMPK activation and exercise-mimetic metabolic signaling, whereas SS-31 and Humanin are better suited for studying mitochondrial membrane stabilization and anti-apoptotic signaling cascades. Investigating all three in comparative assays allows research teams to map comprehensive mitochondrial response networks.
Evaluating a peptide supplier requires scrutinizing manufacturing practices, analytical capabilities, and facility standards. Overseas suppliers offering discounted MOTS-c often lack standardized quality controls, ISO-accredited analytical laboratories, or traceable lot records.
PX1 Research maintains rigorous quality assurance protocols by distributing peptides synthesized in cGMP-compliant facilities within the United States. Every lot undergoes independent verification by third-party ISO 17025 accredited laboratories to confirm identity, purity, and safety metrics prior to inventory release. Learn more about bulk sourcing options through our institutional wholesale supply portal.
In addition to stringent analytical protocols, PX1 Research provides logistical reliability with same-day shipping on orders placed Monday through Friday, operating directly out of distribution centers in California and Arizona. This reduces transit times, protecting temperature-sensitive peptides like MOTS-c from environmental degradation during shipping.
Procuring MOTS-c for scientific investigation requires looking past surface-level price points to evaluate long-term research viability. Low-cost peptides that lack complete analytical documentation introduce uncontrolled variables that threaten experimental validity, lead to wasted reagents, and compromise data integrity.
By prioritizing lot-specific HPLC/MS purity validation, verified endotoxin limits, and domestic USA manufacturing, researchers ensure their assays yield reliable, reproducible data. For complete specifications, technical documentation, and batch verification on MOTS-c and related research reagents, visit the PX1 scientific research hub.
Invest in proven quality to safeguard your laboratory's empirical results. PX1 Research delivers reference-grade, analytical-standard research compounds tailored strictly for in vitro and preclinical research applications.
Why is buying cheap MOTS-c a risk for laboratory research?
Cheap MOTS-c often lacks rigorous post-synthesis purification, resulting in truncated peptide sequences, residual cleavage reagents (TFA, heavy metals), and elevated endotoxin levels. These impurities cause cytotoxicity, alter target binding, and produce non-reproducible data in preclinical assays.
How can I verify the quality and purity of a MOTS-c batch?
Quality is verified by reviewing lot-specific, third-party Certificates of Analysis (COAs) that include Reversed-Phase HPLC (confirming ≥98% purity) and Mass Spectrometry (confirming exact molecular mass of 1220.5 Da), alongside Limulus Amebocyte Lysate (LAL) testing for endotoxin levels.
What primary research areas involve MOTS-c?
MOTS-c is investigated in preclinical research evaluating mitochondrial function, systemic metabolic regulation, AMPK-mediated glucose uptake, GLUT4 translocation, and exercise-capacity adaptation in animal models.
What is the molecular weight and sequence of synthetic MOTS-c?
MOTS-c is a 16-amino-acid peptide with the sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg and a theoretical molecular weight of approximately 1220.5 Da.
How should MOTS-c be stored in the laboratory?
Lyophilized MOTS-c should be stored desiccated at -20°C or -80°C. Reconstituted solutions should be divided into single-use aliquots to avoid freeze-thaw cycles and stored at -80°C for long-term stability.
What solvent is recommended for reconstituting MOTS-c for in vitro work?
For standard laboratory assays, MOTS-c is commonly reconstituted in sterile bacteriostatic water, sterile normal saline, or laboratory-grade PBS, depending on specific assay buffer compatibility.
What are acceptable endotoxin levels for research-grade MOTS-c?
High-quality research-grade peptides should typically demonstrate endotoxin levels under 10 EU/mg (or <0.1 EU/µg) to prevent unwanted inflammatory signaling or cytotoxicity in sensitive cellular assays.
Where is PX1 Research MOTS-c manufactured and shipped from?
PX1 Research compounds are manufactured in domestic U.S. cGMP-compliant facilities and shipped directly from distribution locations in California and Arizona with same-day shipping for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.